AstraZeneca, one of the leading pharmaceutical companies in the world, has announced its decision to withdraw its Covid-19 vaccine globally. This move comes after reports of rare blood clotting issues in some recipients of the vaccine. While AstraZeneca maintains that the benefits of the vaccine outweigh the risks, they have decided to prioritize public safety and halt distribution.
This decision has sparked a debate among health experts and government officials around the world. Some argue that the risks associated with the vaccine are minimal compared to the potential benefits of vaccination in controlling the spread of Covid-19. Others believe that it is better to err on the side of caution and suspend distribution until further investigations can be conducted.
The company's decision comes after reports of rare blood clotting events in some recipients of the vaccine. While AstraZeneca maintains that the benefits of the vaccine outweigh the risks, many countries have paused or limited its use as a precautionary measure. The decision spells the end of the road for the vaccine that was created in collaboration with scientists from Oxford university within months of the outbreak of the pandemic, and approved in the UK in late 2020, with over 3bn doses supplied since its launch. Unlike rivals Pfizer and BioNTech and Moderna, AstraZeneca initially adopted a non-profit model for its vaccine, selling it “at cost” as part of its agreement with Oxford, and the drug played a key role in ending the pandemic. However its rollout was plagued by rare incidents of blood clotting and friction with the European Union over access to the product.
The voluntary withdrawal has started in the EU, with the European Medicines Agency announcing that the vaccine is no longer authorised for use.
In a statement, AZ said: "According to independent estimates, over 6.5 million lives were saved in the first year of use alone and over three billion doses were supplied globally.
"Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic.
The vaccine hasn't been used in the UK since the start of the booster programme, though the government says this was because mRNA vaccines were more effective, not because of concern over side effects.
However, more than 50 people who developed clots after vaccination are taking legal action against AZ in the High Court, claiming that the company failed to adequately inform them of a potential risk.
This development raises questions about the safety and efficacy of Covid-19 vaccines in general. It also highlights the challenges of balancing public health concerns with the need to vaccinate populations quickly and effectively.
As we navigate this unprecedented crisis, it is crucial that we continue to prioritize transparency, communication, and collaboration in our efforts to end the pandemic.
Read more
Storied Producer and Icon of the Rock Underground Steve Albini Dies at 61 Brazil floods: ‘Desperate’ rescues, 150,000 homeless, scores dead or missing
Sarah H
Also on site :
- After dazzling at Coachella, Lady Gaga announces San Francisco arena shows
- Sophie Nyweide, Noah and Mammoth child actor, dies at 24
- Wedding season is upon us. Here’s what to wear to be both chic and comfortable